Sunday, May 23, 2021 5:51:52 PM
Horseb4CarT,
Yes, ENMD had the vision but not the financial support structure. Linda had a plan that included a system of financial support that could go very slowly forward to the point where the evidence was sufficient to gain a backer. Fortunately she also had the support of Providence to buy property that gained significant value to the point that instead of low of $.05 and up to 5,000,000,000 shares and warrants outstanding we have less than 1/3 of that in shares and warrants and the low was $.14.
China was a disaster waiting to happen and the air quality of Beijing during the Olympic and prior should have been a big clue that this was a plague about to break loose upon the Chinese people. Expansion at any cost is what the piper is being paid today and for years to come unless a cure comes to their people. They have needed a product like Direct for a very long time and the need will only grow especially for it’s cheaper component use if proven safe and effective in trials as other preliminary research With other components indicates is possible. Best wishes.
Yes, ENMD had the vision but not the financial support structure. Linda had a plan that included a system of financial support that could go very slowly forward to the point where the evidence was sufficient to gain a backer. Fortunately she also had the support of Providence to buy property that gained significant value to the point that instead of low of $.05 and up to 5,000,000,000 shares and warrants outstanding we have less than 1/3 of that in shares and warrants and the low was $.14.
China was a disaster waiting to happen and the air quality of Beijing during the Olympic and prior should have been a big clue that this was a plague about to break loose upon the Chinese people. Expansion at any cost is what the piper is being paid today and for years to come unless a cure comes to their people. They have needed a product like Direct for a very long time and the need will only grow especially for it’s cheaper component use if proven safe and effective in trials as other preliminary research With other components indicates is possible. Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
